ENTERA BIO LTD (ENTX) Stock Income Statement
NASDAQ:ENTX - Nasdaq - IL0011429839 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 130.00K | 570.00K | 370.00K | 240.00K | |||
| Cost Of Goods | 0.00 | 100.00K | 370.00K | 300.00K | 210.00K | |||
| Gross Profit | 0.00 | 30.00K | 200.00K | 70.00K | 30.00K | |||
| Operating Expenses | 8.89M | 13.05M | 12.42M | 11.23M | 11.48M | |||
| Research and Development | 4.51M | 5.85M | 6.77M | 6.38M | 7.20M | |||
| Selling, General, and Administrative Expenses | 4.43M | 7.25M | 5.69M | 4.85M | 4.28M | |||
| Operating Income | -8.89M | -13.02M | -12.22M | -11.17M | -11.45M | |||
| Interest Income/Expense | 31.00K | 80.00K | -30.00K | -30.00K | 740.00K | |||
| Other Income/Expense | N/A | N/A | N/A | -70.00K | -80.00K | |||
| Income Before Taxes | -8.86M | -12.93M | -12.25M | -11.20M | -10.80M | |||
| Income Tax | 29.00K | 140.00K | -60.00K | 20.00K | N/A | |||
| Net Income | -8.89M | -13.07M | -12.19M | -11.22M | -10.80M | |||
| EBITDA | -8.84M | -12.96M | -12.17M | -11.11M | -11.21M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.31 | -0.45 | -0.47 | -0.61 | -0.89 | |||
| Non GAAP EPS | -0.31 | -0.45 | -0.62 | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | 23.08% | 35.09% | 18.92% | 12.50% | |||
| Profit Margin | N/A | -10053.85% | -2138.60% | -3032.43% | -4500.00% | |||
| Operating Profit Margin | N/A | -10015.38% | -2143.86% | -3018.92% | -4770.83% | |||
All data in USD